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Abstract
Background: The Burkholderia cepacia complex (BCC) is comprised of at least seventeen Gram-negative species
that cause infections in cystic fibrosis patients. Because BCC bacteria are broadly antibiotic resistant, phage therapy
is currently being investigated as a possible alternative treatment for these infections. The purpose of our study
was to sequence and characterize three novel BCC-specific phages: KS5 (vB_BceM-KS5 or vB_BmuZ-ATCC 17616),
KS14 (vB_BceM-KS14) and KL3 (vB_BamM-KL3 or vB_BceZ-CEP511).
Results: KS5, KS14 and KL3 are myoviruses with the A1 morphotype. The genomes of these phages are between
32317 and 40555 base pairs in length and are predicted to encode between 44 and 52 proteins. These phages
have over 50% of their proteins in common with enterobacteria phage P2 and so can be classified as members of
the Peduovirinae subfamily and the “P2-like viruses” genus. The BCC phage proteins similar to those encoded by P2
are predominantly structural components involved in virion morphogenesis. As prophages, KS5 and KL3 integrate
into an AMP nucleosidase gene and a threonine tRNA gene, respectively. Unlike other P2-like viruses, the KS14
prophage is maintained as a plasmid. The P2 E+E’ translational frameshift site is conserved among these three
phages and so they are predicted to use frameshifting for expression of two of their tail proteins. The lysBC genes
of KS14 and KL3 are similar to those of P2, but in KS5 the organization of these genes suggests that they may
have been acquired via horizontal transfer from a phage similar to l. KS5 contains two sequence elements that are
unique among these three phages: an ISBmu2-like insertion sequence and a reverse transcriptase gene. KL3
encodes an EcoRII-C endonuclease/methylase pair and Vsr endonuclease that are predicted to function during the
lytic cycle to cleave non-self DNA, protect the phage genome and repair methylation-induced mutations.
Conclusions: KS5, KS14 and KL3 are the first BCC-specific phages to be identified as P2-like. As KS14 has previously
been shown to be active against Burkholderia cenocepacia in vivo, genomic characterization of these phages is a
crucial first step in the development of these and similar phages for clinical use against the BCC.
Background
The Burkholderia cepacia complex (BCC) is a group of
at least seventeen species of Gram-negative opportunis-
tic pathogens. Although these organisms can infect
patients with a broad range of chronic conditions, the
majority of infections occur in those with cystic fibrosis
(CF) [1,2]. Because the lungs of these individuals contain
thick mucus that cannot be cleared by the mucociliary
escalator, they are susceptible to pulmonary infections
by microorganisms such as Pseudomonas, Staphylococ-
cus, Haemophilus and Burkholderia [3,4]. The
prevalence of BCC infection in American CF patients
was 3.1% in 2005 [5]. Although this prevalence is low
c o m p a r e dt ot h a to fPseudomonas aeruginosa (56.1% in
2005), there are three reasons why the BCC is a serious
problem for the CF population[ 5 ] .F i r s t ,B C Cb a c t e r i a
cause severe and potentially fatal respiratory infections.
When compared to patients infected with Pseudomonas,
those with BCC infections have reduced lung function
and, depending on the species present, increased mortal-
ity [6,7]. In approximately 20% of cases, these indivi-
duals develop a rapidly fatal condition called ‘cepacia
syndrome,’ which is characterized by lung abscesses and
septicemia [2,8]. Second, BCC bacteria can spread from
person-to-person. It has been shown that at least five
BCC species can be transmitted in this manner:
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kholderia cenocepacia, Burkholderia dolosa and Burkhol-
deria contaminans [9-11]. Because of the potential for
these organisms to spread among a susceptible popula-
tion, BCC culture-positive patients are isolated from
other individuals with CF, a measure that has serious
social and psychological implications [12,13]. Finally,
BCC bacteria are resistant to most antibiotics. These
species have a variety of resistance mechanisms includ-
ing b-lactamases, efflux pumps and biofilm formation
[14-16]. The most effective anti-BCC antibiotics - cefta-
zidime, meropenem and minocycline - only inhibit
between 23-38% of clinical isolates [17].
Because conventional antibiotics are largely ineffective
against the BCC, phage therapy is being explored as a
possible alternative treatment. Phage therapy is the clini-
cal administration of bacteriophages (or phages) to pre-
vent and/or to treat bacterial infections [18]. Although
phages have been used therapeutically for almost a cen-
tury, this treatment fell out of favor in North America
and Western Europe when penicillin and other chemical
antibiotics became widely available in the 1940s [18].
However, there has been renewed interest in this field
following the emergence of multidrug resistant bacteria
such as those of the BCC [18]. Three recent studies
have shown that phages are active against the BCC
in vivo. Seed and Dennis showed that treatment of
B. cenocepacia-infected Galleria mellonella larvae with
phages KS14, KS4-M or KS12 increased survival 48
hours post-infection, even when treatment with the lat-
ter two phages was delayed for 6 to 12 hours [19].
Carmody et al. showed that intraperitoneal administra-
tion of phage BcepIL02 to B. cenocepacia-infected mice
decreased bacterial density in the lungs and led to
decreased expression of the pro-inflammatory cytokines
MIP-2 and TNF-a [20]. Lynch et al. published the first
description of an engineered BCC phage and showed
that this mutant (a repressor knockout of phage KS9)
w a sa b l et oi n c r e a s es u r v i v a lo fB. cenocepacia-infected
G. mellonella 48 hours post-infection [21].
Before a phage can be safely used clinically, its com-
p l e t eg e n o m es e q u e n c em u s tb ed e t e r m i n e dt oa s s e s s
whether the phage is obligately lytic or temperate, and
to determine by homology whether the phage genome
encodes any putative virulence factors. This report
describes the genome sequence of three novel BCC
phages and their relatedness to enterobacteria phage P2.
P2 is a temperate myovirus that was isolated from
E. coli strain Li by Bertani in 1951 [22]. P2 has recently
been classified as part of a novel subfamily, placing it in
the order Caudovirales,f a m i l yMyoviridae,s u b f a m i l y
Peduovirinae and genus “P2-like viruses” [23]. This
genus includes phages P2, Wj, 186 and PsP3 of entero-
bacteria, L-413C of Yersinia,F e l s - 2a n dS o p E j of
Salmonella, j-MhaA1-PHL101 of Mannheimia, jCTX
of Pseudomonas,R S A 1o fRalstonia, jE202 of Burkhol-
deria thailandensis and j52237 and jE12-2 of Burkhol-
deria pseudomallei [23]. Based on sequence analysis, it
is proposed that the BCC-specific phages KS5
(vB_BceM-KS5 or vB_BmuZ-ATCC 17616), KS14
(vB_BceM-KS14) and KL3 (vB_BamM-KL3 or vB_BceZ-
CEP511) should also be classified as part of this genus
[24].
Results and Discussion
Isolation, host range and morphology
Seed and Dennis isolated KS5 from an extract of onion
soil plated on B. cenocepacia K56-2 [25]. This phage
produces clear plaques on K56-2 with a diameter of 0.5-
1.0 mm [25]. Previously, KS5 was tested for its ability to
form plaques on K56-2 LPS mutants and it was deter-
mined that it could efficiently lyse wildtype K56-2 (EOP
=1 ) ,X O A 7( waaL::pGPΩTp, EOP = 0.8), XOA15
(wabR::pGPΩTp, EOP = 1.3), XOA17 (wabS::pGPΩTp,
EOP = 1.1) and RSF19 (wbxE::pGPΩTp, EOP = 0.5), but
not XOA8 (wabO::pGPΩTp) or CCB1 (waaC::pGPΩTp)
[21,26,27]. Based on these results, it was predicted that
KS5 uses the K56-2 LPS as a receptor and that it binds
within the core region [21]. KS5 has a relatively wide
host range compared to many BCC phages, infecting B.
multivorans C5393 and B. cenocepacia 715J, J2315, K56-
2, C6433 and C5424 [25].
KS14 was isolated from an extract of Dracaena sp. soil
plated on B. multivorans C5393 [19]. Both BCC phages
and bacteria have been recovered from the Dracaena
rhizosphere [19,28]. On C5393, KS14 forms small clear
plaques 0.5-1.0 mm in diameter, similar to the morphol-
ogy of KS5 on K56-2. The host range of KS14 includes
B. multivorans C5393 and C5274, B. cenocepacia 715J,
C6433, C5424 and PC184, B. dolosa LMG 21443 and
Burkholderia ambifaria LMG 17828 [19].
KL3 was isolated from a single plaque on a lawn of
B. cenocepacia CEP511, an Australian CF epidemic iso-
late [29]. Phage induction from CEP511 was stochastic,
as treatment with inducing agents such as UV or mito-
mycin C was not necessary. On LMG 17828, KL3 forms
small turbid plaques 0.5-1.0 mm in diameter. KL3 has a
narrow host range, infecting B. ambifaria LMG 17828.
Electron microscopy of KS5, KS14 and KL3 indicates
that these phages belong to the family Myoviridae (Fig-
ure 1). These three phages exhibit the A1 morphotype,
with icosahedral capsids and contractile tails [30]. KS5,
KS14 and KL3 have similarly sized capsids, each 65 nm
in diameter (Figure 1). In contrast, their tails vary in
length: 140 nm for KS14, 150 nm for KS5 and 160 nm
for KL3 (Figure 1). These sizes correspond to the length
of the tail tape measure protein for each of these three
phages: KS14 gp12 is 842 amino acids (aa) in length,
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2 and 3).
Genome characterization
KS5
The KS5 genome is 37236 base pairs (bp) in length and
encodes 46 proteins (including the transposase of a pre-
dicted insertion sequence, discussed below) (Table 1).
This genome has a 63.71% G+C content. Forty-three of
the start codons are ATG, 2 are GTG and 1 is TTG
(Table 1). As KS5 was isolated from an environmental
sample, it was predicted that this phage might be obli-
gately lytic [25]. However, KS5 encodes an integrase and
a repressor and is found as ap r o p h a g ei nc h r o m o s o m e
2o ft h ef u l l ys e q u e n c e dB. multivorans strain ATCC
17616 (GenBank:NC_010805.1; BMULJ_03640-
BMULJ_03684, bp 477496-514731) (Table 1). Because of
this similarity, the possibility exists that KS5 originated
from ATCC 17616 or a closely related strain found in
the soil enrichment. Excluding the ATCC 17616 proph-
age, KS5 is most similar to a putative prophage element
in Burkholderia multivorans CGD1. Twenty-three of 46
KS5 proteins are most closely related to a protein from
CGD1, with percent identities ranging from 72-99%
(Table 1).
KS14
The KS14 genome is 32317 bp in length and encodes 44
proteins (Table 2). This genome has a 62.28% G+C con-
tent. Forty-one of the start codons are ATG, 2 are GTG
and 1 is TTG (Table 2). All predicted KS14 proteins
show similarity to at least one protein in the database
(as determined by a BLASTP search) except for gp38
and gp42. The protein with the most similarity to others
in the database is the terminase large subunit, gp35,
which has 75% identity with a protein of unknown func-
tion DUF264 of Burkholderia sp. CCGE1001. Aside
from gp38 and gp42, the least similar protein is the
hypothetical protein gp39, which has 29% identity with
the flagellar hook-associated protein FlgK of Acidovorax
ebreus TPSY (Table 2).
KL3
The KL3 genome is 40555 bp in length and encodes 52
proteins (Table 3). This genome has a 63.23% G+C con-
tent. Fifty-one of the start codons are ATG and 1 is GTG
(Table 3). Similarly to KS14, all predicted KL3 proteins
show similarity to at least one protein in the database
except for gp43. The proteins with the most similarity to
others in the database are the terminase large subunit
(gp41) and the portal protein (gp42) that have 99% iden-
tity with Burkholderia glumae BGR1 proteins and the
hypothetical protein gp50 which has 99% identity with a
B. ambifaria MEX-5 protein. Aside from gp43, the least
similar protein is the hypothetical protein gp14, which
has 50% identity with the hypothetical protein
BuboB_27112 of Burkholderia ubonensis Bu (Table 3).
Modular organization
T h eg e n o m em a p so fK S 5 ,K S 1 4a n dK L 3a r es h o w ni n
Figure 2. Each of these phages has a modular organiza-
tion, with genes for tail formation (shown in purple),
lysis (shown in light blue) and head formation (shown
in dark blue) clustered in each phage (Figure 2). In KS5,
genes 13-19, 22-27, 29-30 and 36 encode tail proteins,
Figure 1 Transmission electron micrographs of KS5 (A), KS14 (B) and KL3 (C). Phages were stained with 2% phosphotungstic acid and
viewed at 140,000-fold magnification. Scale bars represent 50 nm.
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Gene Start End Putative
function
Strand Predicted RBS and start
codon
Length
(no. of
aa
residues)
Closest relative
(excluding
ATCC 17616)
Alignment
region (no.
of aa
residues)
%
ID
Source GenBank
accession no.
ATCC 17616
locus tag
ATCC 17616
GenBank
accession no.
1 108 815 integrase - AGCAACAAGcacaaggcaTTG 235 integrase family
protein
134-368/
368
87 Burkholderia
thailandensis
MSMB43
ZP_02468407.1 BMULJ_03640 YP_001948048.1
2 2142 4937 zinc finger
CHC2-family
protein
- GAGCAACAGcaataacgATG 931 conserved
hypothetical
protein
1-931/931 96 Burkholderia
multivorans CGD1
ZP_03587581.1 BMULJ_03641 YP_001948049.1
3 4940 5200 unknown - GGGGGAAGccgcATG 86 conserved
hypothetical
protein
1-86/86 91 Burkholderia
multivorans CGD1
ZP_03587582.1 BMULJ_03642 YP_001948050.1
4 5197 5556 unknown - GGGGGTGAtgtgATG 119 conserved
hypothetical
protein
1-119/119 97 Burkholderia
multivorans CGD1
ZP_03587583.1 BMULJ_03643 YP_001948051.1
5 5561 5755 membrane
protein
- GGAGccaaaccATG 64 putative phage-
encoded
membrane
protein
1-64/64 78 Burkholderia
ambifaria MEX-5
ZP_02905725.1 BMULJ_03644 YP_001948052.1
6 5798 6001 unknown - GGATGcactgaccgATG 67 conserved
hypothetical
protein
1-67/67 92 Burkholderia
multivorans CGD1
ZP_03587585.1 BMULJ_03645 YP_001948053.1
7 6005 6199 unknown - GGAGAGActcATG 64 conserved
hypothetical
protein
1-64/64 98 Burkholderia
multivorans CGD1
ZP_03587586.1 BMULJ_03646 YP_001948054.1
8 6289 6537 transcriptional
activator (Ogr)
- GTAGGAGccccgaATG 82 transcriptional
activator Ogr/
delta
1-82/82 91 Burkholderia
cenocepacia MC0-
3
YP_001763475.1 BMULJ_03647 YP_001948055.1
9 6547 6825 DNA binding
protein
- GGGCGttgagtcATG 92 putative phage
DNA-binding
protein
1-92/92 98 Burkholderia
ambifaria MEX-5
ZP_02905729.1 BMULJ_03648 YP_001948056.1
10 6829 7065 unknown - GAAGGGAAGtataccgtcATG 78 putative
bacteriophage
protein
1-77/78 80 Burkholderia sp.
CCGE1001
ZP_06292840.1 BMULJ_03649 YP_001948057.1
11 7121 7603 repressor + GATAATACAcaccgatcgGTG 160 putative phage
DNA-binding
protein
12-166/167 79 Burkholderia
pseudomallei
K96243
YP_106769.1 BMULJ_03650 YP_001948058.1
12 7660 8406 membrane
protein
+ AGGGAAttcaATG 248 putative phage-
encoded
membrane
protein
1-241/249 43 Burkholderia
pseudomallei
K96243
YP_106770.1 BMULJ_03651 YP_001948059.1
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6Table 1 KS5 genome annotation (Continued)
ISBmu23 8976 10185 ISBmu23
insertion
sequence
8976 8991 ISBmu23
inverted
repeat
9063 10055 ISBmu23
transposase
+ GGAACGGAcccacgacgATG 330 transposase IS4
family protein
1-330/330 100 Burkholderia sp.
Ch1-1
ZP_06846513.1 BMULJ_03652 YP_001948060.1
10170 10185 ISBmu23
inverted
repeat
10185 10189 direct repeat
flanking
ISBmu23
13 10359 11510 tail protein (D) - AAGGAGGcgatctcgctATG 383 phage late
control gene D
protein
1-379/382 96 Burkholderia
multivorans CGD1
ZP_03587594.1 BMULJ_03653 YP_001948061.1
14 11507 11935 tail protein (U) - GAAGGAGGGAttgtcATG 142 bacteriophage
gpU
1-142/142 95 Burkholderia
multivorans CGD1
ZP_03587595.1 BMULJ_03654 YP_001948062.1
15 11949 14711 tail tape
measure
protein (T)
- GAGCGAGGcgacgaATG 920 putative phage-
related tail
transmembrane
protein
1-919/919 91 Burkholderia
cenocepacia MC0-
3
YP_001763483.1 BMULJ_03655 YP_001948063.1
16 14827 15138 tail protein (E) - AGAGGAAccatacgATG 103 phage tail
protein E
1-103/103 97 Burkholderia
multivorans CGD1
ZP_03587598.1 BMULJ_03657 YP_001948065.1
17 14708 15138 tail protein (E
+E’)
- AGAGGAAccatacgATG 143 phage tail
protein E
1-87/103 97 Burkholderia
multivorans CGD1
ZP_03587598.1 BMULJ_03656
BMULJ_03657
YP_001948064.1
YP_001948065.1
18 15171 15680 tail tube
protein (FII)
- AGGGAAAcgcaATG 169 phage major tail
tube protein
1-169/169 94 Burkholderia
multivorans CGD1
ZP_03587599.1 BMULJ_03658 YP_001948066.1
19 15710 16882 tail sheath
protein (FI)
- GGGAGAttgcATG 390 tail sheath
protein
1-390/390 94 Burkholderia
cenocepacia MC0-
3
YP_001763487.1 BMULJ_03659 YP_001948067.1
20 16993 17742 N-4/N-6 DNA
methylase
- GAGGGAAtcgccccATG 249 DNA methylase
N-4/N-6 domain
protein
1-249/249 89 Burkholderia
ambifaria MEX-5
ZP_02905740.1 BMULJ_03660 YP_001948068.1
21 17720 17902 Com
translational
regulator
- AAGCAGGAAtcacccgATG 60 hypothetical
protein
Bcenmc03_0187
1-60/60 85 Burkholderia
cenocepacia MC0-
3
YP_001763489.1 BMULJ_03661 YP_001948069.1
22 18049 18927 tail fiber
assembly
protein
- GAGACACAcctATG 292 gp31,
bacteriophage-
acquired
protein
1-272/278 89 Burkholderia
multivorans CGD1
ZP_03587603.1 BMULJ_03662 YP_001948070.1
23 18937 20547 tail fiber
protein
- GGATAcctgaacATG 536 bacteriophage
protein
1-536/536 99 Burkholderia
multivorans CGD1
ZP_03587604.1 BMULJ_03663 YP_001948071.1
L
y
n
c
h
e
t
a
l
.
B
M
C
G
e
n
o
m
i
c
s
2
0
1
0
,
1
1
:
5
9
9
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
1
6
4
/
1
1
/
5
9
9
P
a
g
e
5
o
f
2
6Table 1 KS5 genome annotation (Continued)
24 20550 21104 baseplate
assembly
protein (I)
- GGGGTGGccgATG 184 ZP_03587605.1 1-184/184 92 Burkholderia
multivorans CGD1
ZP_03587605.1 BMULJ_03664 YP_001948072.1
25 21097 22002 baseplate
assembly
protein (J)
- GAGGCAcggcATG 301 ZP_03587606.1 1-301/301 94 Burkholderia
multivorans CGD1
ZP_03587606.1 BMULJ_03665 YP_001948073.1
26 21999 22376 ZP_03587607.1 - GAAGGGGcacggATG 125 baseplate
assembly
protein W
(GpW)
1-125/125 89 Burkholderia
multivorans CGD1
ZP_03587607.1 BMULJ_03666 YP_001948074.1
27 22373 23005 baseplate
assembly
protein (V)
- GCGGCAtccttgccgcATG 210 YP_001763496.1 1-137/234 78 Burkholderia
cenocepacia MC0-
3
YP_001763496.1 BMULJ_03667 YP_001948075.1
28 23206 25086 exonuclease
(Old)
- AAGTGGGGAccaactATG 626 ATP-dependent
endonuclease
1-625/626 72 Cupriavidus
metallidurans
CH34
YP_586772.1 BMULJ_03668 YP_001948076.1
29 25269 25718 tail
completion
protein (S)
- GGGGAcgtgATG 149 phage virion
morphogenesis
protein
1-148/149 89 Burkholderia
multivorans CGD1
ZP_03587610.1 BMULJ_03669 YP_001948077.1
30 25718 26128 tail
completion
protein (R)
- AGGAGGcgccGTG 136 P2 phage tail
completion
protein R (GpR)
1-136/136 96 Burkholderia
multivorans CGD1
ZP_03587611.1 BMULJ_03670 YP_001948078.1
31 26172 26366 Rz1 - AAGGAGGttccggtttATG 64 Ribonuclease,
Rne/Rng family
15-48/928 47 Propionibacterium
freudenreichii
subsp. shermanii
CIRM-BIA1
YP_003687809.1 none
32 26125 26616 Rz - GGGTGGccgcATG 163 conserved
hypothetical
protein
1-163/163 85 Burkholderia
ambifaria MEX-5
ZP_02905751.1 BMULJ_03671 YP_001948079.1
33 26613 27413 endolysin - GGGGGcgccATG 266 peptidoglycan
binding
domain-
containing
protein
1-266/266 90 Burkholderia
cenocepacia MC0-
3
YP_001763501.1 BMULJ_03672 YP_001948080.1
34 27406 27726 holin - AAGGGGAGGGAcaagtgATG 106 protein of
unknown
function
DUF754
1-106/106 88 Burkholderia
ambifaria MEX-5
ZP_02905753.1 BMULJ_03673 YP_001948081.1
35 27726 28100 putative
antiholin
- ATGGGActgagaATG 124 phage-related
transmembrane
protein
1-124/124 96 Burkholderia
multivorans CGD1
ZP_03587615.1 BMULJ_03674 YP_001948082.1
36 28103 28315 tail protein (X) - AGGGAGctgtcctgATG 70 tail X family
protein
1-70/70 94 Burkholderia
cenocepacia MC0-
3
YP_001763504.1 BMULJ_03675 YP_001948083.1
37 28315 28557 unknown - GTGGAGctcatctgATG 80 conserved
hypothetical
protein
1-80/80 72 Burkholderia
multivorans CGD1
ZP_03587617.1 BMULJ_03676 YP_001948084.1
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6Table 1 KS5 genome annotation (Continued)
38 28557 29033 capsid
completion
protein (L)
- AACGTGACGAAcccgaccATG 158 head
completion
protein
1-160/160 85 Burkholderia
ambifaria MEX-5
ZP_02905755.1 BMULJ_03677 YP_001948085.1
39 29138 29824 terminase
endonuclease
subunit (M)
- GGGTGGcgcATG 228 terminase 1-228/228 93 Burkholderia
multivorans CGD1
ZP_03587619.1 BMULJ_03678 YP_001948086.1
40 29821 30846 capsid protein
(N)
- AAACGGAGAAtccATG 341 phage major
capsid protein,
P2 family
1-339/339 77 Burkholderia
ambifaria MEX-5
ZP_02905757.1 BMULJ_03679 YP_001948087.1
41 30884 31705 capsid
scaffolding
protein (O)
- AGAGGtttcgcacATG 273 phage capsid
scaffolding
protein GpO
1-273/273 95 Burkholderia
multivorans CGD1
ZP_03587621.1 BMULJ_03680 YP_001948088.1
42 31855 33621 terminase
ATPase
subunit (P)
+ GGTAGccttgctgcATG 588 putative ATPase
subunit of
terminase (gpP-
like)
1-583/583 92 Burkholderia
multivorans CGD1
ZP_03587622.1 BMULJ_03681 YP_001948089.1
43 33621 34673 portal vertex
protein (Q)
+ ATGGAGAttttctgATG 350 phage portal
protein, pbsx
family
1-348/349 92 Burkholderia
multivorans CGD1
ZP_03587623.1 BMULJ_03682 YP_001948090.1
44 35144 36163 reverse
transcriptase
- GAATGGAtttccgaaaATG 339 putative reverse
transcriptase
2-285/292 42 Sideroxydans
lithotrophicus ES-1
YP_003522714.1 BMULJ_03683 YP_001948091.1
45 36120 36443 transcriptional
regulator
- GAAGGAGttgcatATG 107 transcriptional
regulator
1-97/97 52 Acinetobacter
baumannii ACICU
YP_001840883.1 BMULJ_03684 YP_001948092.1
Abbreviations: RBS, ribosome-binding site; aa, amino acid, % ID, percent identity. The P2 proteins that are similar to KS5 proteins based on CoreGenes analysis are shown in brackets in the putative function column.
Excluding genes 17 and 31, annotations were based on those of the B. multivorans ATCC 17616 chromosome 2 sequence (NC_010805.1; BMULJ_03640 - BMULJ_03684, bp 477496-514731).
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6Table 2 KS14 genome annotation
Gene Start End Putative
function
Strand Predicted RBS and start
codon
Length (no.
of aa
residues)
Closest relative Alignment region
(no. of aa
residues)
%
ID
Source GenBank
accession no.
1 1 261 unknown - GAGGCGAggcATG 86 hypothetical protein
BB1680
18-96/101 35 Bordetella bronchiseptica
RB50
NP_888225.1
2 270 3041 zinc finger CHC2-
family protein
- GCGATTCTGAaaaATG 923 hypothetical protein
RPRSA1_gp47
1-933/934 65 Ralstonia phage phiRSA1 YP_001165296.1
3 3122 3511 unknown - GAGGGAccgaaccATG 129 hypothetical protein
Csal_1360
9-103/130 33 Chromohalobacter
salexigens DSM 3043
YP_573414.1
4 3857 4036 unknown - GAAAAcaccATG 59 hypothetical protein
PC1_2629
21-62/63 45 Pectobacterium
carotovorum subsp.
carotovorum PC1
YP_003018195.1
5 4142 4849 repressor + AAGGcccaatATG 235 hypothetical protein
GCWU000324_01220
13-220/226 33 Kingella oralis ATCC 51147 ZP_04601747.1
6 4809 5486 serine
recombinase
- GAAGGCGAtacaagaaaATG 225 resolvase domain-
containing protein
4-194/195 57 Shewanella sp. W3-18-1 YP_965429.1
7 5479 5790 unknown - GAGGCGGGcgagctATG 103 hypothetical protein
BuboB_03089
9-106/114 45 Burkholderia ubonensis Bu ZP_02376681.1
8 5787 6368 unknown - GACTACAGGcgaccATG 193 hypothetical protein
pRALTA_0144
25-180/255 48 Cupriavidus taiwanensis YP_001796036.1
9 6506 7054 unknown + AGGAAAGAAAAcggtcgtTTG 182 hypothetical protein
Ajs_3318
20-138/138 31 Acidovorax sp. JS42 YP_987516.1
10 7093 8130 tail protein (D) - AAAAAagaATG 345 fels-2 prophage protein 25-366/366 65 Burkholderia oklahomensis
EO147
ZP_02353972.1
11 8127 8558 tail protein (U) - GGAGGAAAGAAAcgATG 143 bacteriophage tail-related
protein
1-133/141 64 Burkholderia oklahomensis
EO147
ZP_02353973.1
12 8574 11102 tail tape measure
protein (T)
- GTATGGAAGcgaATG 842 phage tail tape measure
protein, TP901 family
5-918/924 39 Pantoea sp. At-9 b ZP_05730476.1
13 11251 11535 tail protein (E) - AGAGAAAgaaATG 94 hypothetical protein
BPSL0148
12-103/114 72 Burkholderia pseudomallei
K96243
YP_106776.1
14 11099 11535 tail protein (E+E’) - AGAGAAAgaaATG 145 gpE+E’ 3-142/142 49 Enterobacteria phage P2 NP_046780.1
15 11623 12138 tail tube protein
(FII)
- AGGGAGtaaATG 171 phage major tail tube
protein
1-169/169 66 Burkholderia sp. CCGE1001 ZP_06292830.1
16 12150 13325 tail sheath
protein (FI)
- AAACAGGAAttcagATG 391 putative phage major tail
sheath protein
1-390/390 72 Burkholderia cenocepacia
J2315
YP_002229261.1
17 13387 14007 tail fiber assembly
protein (G)
- GAAGGGAAccgaccATG 206 gp31, bacteriophage-
acquired protein
1-189, 196-266/278 66,
54
Burkholderia multivorans
CGD1
ZP_03587603.1
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6Table 2 KS14 genome annotation (Continued)
18 14026 15534 tail fiber protein - ACGGATAtctgacctATG 502 hypothetical protein
BuboB_27067
3-534/534 55 Burkholderia ubonensis Bu ZP_02381413.1
19 15538 16080 baseplate
assembly protein
(I)
- GGGGGCAtttacgaaaATG 180 phage-related tail protein 1-179/180 73 Burkholderia ubonensis Bu ZP_02381412.1
20 16073 16987 baseplate
assembly protein
(J)
- AACGGGGGTGcggcATG 304 phage baseplate assembly
protein
1-303/304 74 Burkholderia ubonensis Bu ZP_02381411.1
21 16984 17346 baseplate
assembly protein
(W)
- GTGAGCGCAccgcaATG 120 phage baseplate assembly
protein
1-117/117 66 Burkholderia thailandensis
MSMB43
ZP_02466378.1
22 17343 18002 baseplate
assembly protein
(V)
- AACATGGAggcATG 219 bacteriophage baseplate
assembly protein V
1-227/227 57 Burkholderia ubonensis Bu ZP_02381409.1
23 18087 18545 tail completion
protein (S)
- GATCCGGCGGcgcaATG 152 phage virion
morphogenesis protein
1-153/155 66 Burkholderia sp. CCGE1001 ZP_06292822.1
24 18533 18985 tail completion
protein (R)
- ACCGcccccgaccATG 150 P2 phage tail completion R
family protein
1-136/140 54 Burkholderia sp. CCGE1001 ZP_06292821.1
25 18978 19256 Rz1 (LysC) - GAGGCGttgaaacATG 92 hypothetical phage protein 1-83/91 59 Burkholderia pseudomallei
1655
ZP_04890536.1
26 19102 19554 Rz (LysB) - GAGAAGGcggccgcATG 150 putative phage-encoded
lipoprotein
19-142/142 44 Burkholderia glumae BGR1 YP_002910045.1
27 19551 20357 endolysin - GCGGAGtgaATG 268 putative phage-encoded
peptidoglycan binding
protein
5-268/268 66 Burkholderia ubonensis Bu ZP_02376668.1
28 20354 20620 holin - GAAAGGGctgacccATG 88 protein of unknown
function DUF754
1-88/88 61 Burkholderia sp. CCGE1001 ZP_06292819.1
29 20624 20965 putative antiholin - GGAGtcgccaacATG 113 hypothetical protein
BuboB_26997
1-113/114 74 Burkholderia ubonensis Bu ZP_02381399.1
30 20980 21186 tail protein (X) - GATCGAGctgatctgATG 68 putative phage tail protein 1-67/67 61 Erwinia tasmaniensis Et1/
99
YP_001906519.1
31 21186 21677 capsid
completion
protein (L)
- AGAGctgaaaccATG 163 fels-2 prophage protein 31-172/172 55 Burkholderia thailandensis
E264
YP_439544.1
32 21779 22465 terminase,
endonuclease
subunit (M)
- AACGGAGGcatgacgcgATG 228 bacteriophage terminase,
endonuclease subunit
3-220/229 59 Burkholderia oklahomensis
EO147
ZP_02360025.1
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6Table 2 KS14 genome annotation (Continued)
33 22481 23497 capsid protein (N) - GGAGAAcacaccacATG 338 bacteriophage protein 1-338/338 68 Ralstonia solanacearum
GMI1000
NP_520058.1
34 23540 24577 capsid scaffolding
protein (O)
- GGAGAcctaacaATG 345 capsid scaffolding 4-349/349 50 Burkholderia sp. CCGE1001 ZP_06292813.1
35 24693 26507 terminase ATPase
subunit (P)
+ GGGTACAcataggcgggcGTG 604 protein of unknown
function DUF264
13-586/588 75 Burkholderia sp. CCGE1001 ZP_06292812.1
36 26507 27559 portal vertex
protein (Q)
+ ATGGAGttctcttaATG 350 putative phage portal
vertex protein
1-347/351 70 Burkholderia pseudomallei
7894
ZP_02487524.1
37 27740 28495 replication
initiation
- AGGGGAAGcgtcccaATG 251 initiator RepB protein 16-251/251 73 Ralstonia pickettii 12J YP_001901323.1
38 28834 29010 unknown + GTGAGGGGcaacaaGTG 58 none
39 29150 29695 unknown + GTGATGCACGAccgcccgaATG 181 flagellar hook-associated
protein FlgK
257-334/672 29 Acidovorax ebreus TPSY YP_002554543.1
40 30436 31086 DNA partitioning + GGAGCATGcgaaATG 216 ParA family protein,
putative
1-211/217 69 Burkholderia thailandensis
E264
YP_439556.1
41 31127 31438 unknown + AGCGAGGtaatagcaaaATG 103 hypothetical protein
BuboB_03094
1-73/88 49 Burkholderia ubonensis Bu ZP_02376682.1
42 31435 31581 unknown + AAAGAGGGggcATG 48 none
43 31603 31821 unknown + GAAAAGGGGAAttgaATG 72 hypothetical protein
SMR0083
10-63/63 57 Serratia marcescens NP_941157.1
44 31909 32217 unknown - GGAGTGAtgtttATG 102 hypothetical protein
BuboB_03104
1-69/84 73 Burkholderia ubonensis Bu ZP_02376684.1
Abbreviations: RBS, ribosome-binding site; aa, amino acid; % ID, percent identity. The P2 proteins that are similar to KS14 proteins based on CoreGenes analysis are shown in brackets in the putative function column.
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6Table 3 KL3 genome annotation
Gene Start End Putative
function
Strand Predicted RBS and start
codon
Length (no.
of aa
residues)
Closest relative Alignment region
(no. of aa
residues)
%
ID
Source GenBank
accession no.
1 122 1150 integrase - GGCGCAGtgtgATG 342 integrase family protein 1-342/342 98 Burkholderia ambifaria
MEX-5
ZP_02905720.1
2 1150 1416 unknown - GAAAAtcaccATG 88 hypothetical protein
BamMEX5DRAFT_1075
1-88/88 97 Burkholderia ambifaria
MEX-5
ZP_02905721.1
3 2096 4891 zinc finger CHC2-
family protein
- AACAGCAAtaacgATG 931 zinc finger CHC2-family
protein
1-931/931 95 Burkholderia ambifaria
MEX-5
ZP_02905722.1
4 4894 5142 unknown - GGAGGcgcagcagcATG 82 conserved hypothetical
protein
1-82/84 91 Burkholderia ambifaria
MEX-5
ZP_02905723.1
5 5139 5501 unknown - GCGGGGctgacacgATG 120 conserved hypothetical
protein
1-120/120 97 Burkholderia ambifaria
MEX-5
ZP_02905724.1
6 5506 5700 membrane
protein
- GGAAccacaccATG 64 putative phage-encoded
membrane protein
1-64/64 93 Burkholderia ambifaria
MEX-5
ZP_02905725.1
7 5744 5938 unknown - GCACTGAtccgATG 64 hypothetical protein
bglu_1 g03740
1-64/64 95 Burkholderia glumae BGR1 YP_002910278.1
8 5943 6155 unknown - GAAAAAAGGAGAtcagcATG 70 conserved hypothetical
protein
1-70/70 72 Burkholderia sp. CCGE1001 ZP_06292843.1
9 6243 6491 transcriptional
activator (Ogr)
- GGAGTAAGccgaaATG 82 putative phage
transcriptional activator
Ogr/Delta
1-82/82 92 Burkholderia glumae BGR1 YP_002910024.1
10 6479 6682 unknown - AATGAGTAGctcctacgATG 67 hypothetical protein
BoklE_00724
1-67/67 85 Burkholderia oklahomensis
EO147
ZP_02353966.1
11 6722 6919 unknown - GAGGAGcccgcATG 65 hypothetical protein
BoklE_00729
1-65/65 87 Burkholderia oklahomensis
EO147
ZP_02353967.1
12 6934 7143 unknown - AAAGTATAccgaccATG 69 hypothetical protein
BoklE_00734
1-62/71 87 Burkholderia oklahomensis
EO147
ZP_02353968.1
13 7193 7732 repressor + GGTAAGGctagtgtaATG 179 hypothetical protein
BCAL0086
1-163/163 62 Burkholderia cenocepacia
J2315
YP_002229252.1
14 7904 8179 unknown + GAGGGAccagaagaATG 91 hypothetical protein
BuboB_27112
1-91/98 50 Burkholderia ubonensis Bu ZP_02381422.1
15 8238 9329 tail protein (D) - GGACGCGGAGccgaaggcATG 363 fels-2 prophage protein 19-366/366 81 Burkholderia oklahomensis
EO147
ZP_02353972.1
16 9326 9784 tail protein (U) - ACGGAGGAtctgtcccATG 152 bacteriophage tail-related
protein
1-133/141 66 Burkholderia oklahomensis
EO147
ZP_02353973.1
17 9806 13033 tail tape measure
protein (T)
- GAAGCGGAcacgagtaacgATG 1075 hypothetical protein
bglu_1 g01240
1-1079/1079 59 Burkholderia glumae BGR1 YP_002910030.1
18 13158 13508 tail protein (E) - AGGACACGcaacatATG 116 gpE+E’ 1-114/114 76 Burkholderia pseudomallei
112
ZP_02501899.1
19 13036 13508 tail protein (E+E’) - AGGACACGcaacatATG 157 gpE+E’ 1-100/114 74 Burkholderia pseudomallei
112
ZP_02501899.1
20 13578 14087 tail tube protein
(FII)
- AGGAGtcacacacATG 169 phage major tail tube
protein
1-169/169 74 Burkholderia cenocepacia
J2315
YP_002229260.1
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6Table 3 KL3 genome annotation (Continued)
21 14103 15275 tail sheath
protein (FI)
- AGGAGctgcacaccATG 390 phage tail sheath protein 1-390/390 84 Burkholderia pseudomallei
1655
ZP_04890547.1
22 15328 15951 tail fiber
assembly protein
- ACGGAcctcgaaacATG 207 tail fiber assembly protein
from lambdoid prophage
e14
1-190/209 85 Burkholderia ubonensis Bu ZP_02381414.1
23 15969 18632 tail fiber protein - GGATAcctgaacATG 887 putative phage tail protein 1-883/883 71 Burkholderia cenocepacia
J2315
YP_002229263.1
24 18635 19189 baseplate
assembly protein
(I)
- GATGGCGGGGtcgcggATG 184 phage-related tail protein 1-183/184 84 Burkholderia pseudomallei
7894
ZP_02487653.1
25 19182 20087 baseplate
assembly protein
(J)
- GAACGGAGtcggcgcATG 301 baseplate J-like protein 1-301/301 90 Burkholderia thailandensis
E264
YP_439531.1
26 20084 20446 baseplate
assembly protein
(W)
- GGAGCGGtgcATG 120 phage baseplate assembly
protein
1-117/120 78 Burkholderia pseudomallei
7894
ZP_02487655.1
27 20443 21138 baseplate
assembly protein
(V)
- GAGGGCGGccggcaacATG 231 phage baseplate assembly
protein
33-261/261 72 Burkholderia phage j52237 YP_293735.1
28 21304 22080 N-4/N-6 DNA
methylase
+ ACGTTGcctcagaaccATG 258 site-specific DNA
methyltransferase
34-290/291 78 Burkholderia pseudomallei
K96243
YP_111089.1
29 22060 22527 tail completion
protein (S)
- GAGCAATGGGtggcgtgATG 155 phage virion
morphogenesis protein
1-155/155 87 Burkholderia thailandensis
MSMB43
ZP_02466375.1
30 22527 22943 tail completion
protein (R)
- AGACGGccgcccATG 138 bacteriophage tail
completion protein R
1-138/138 73 Burkholderia pseudomallei
K96243
YP_111086.1
31 22936 23220 Rz1 (LysC) - GGAGActcatcgATG 94 hypothetical phage protein 1-83/91 75 Burkholderia pseudomallei
1655
ZP_04890536.1
32 23057 23497 Rz (LysB) - GAAGGcggccgcGTG 146 protein lysB 1-146/146 62 Burkholderia thailandensis
E264
YP_439538.1
33 23494 24303 endolysin - GGAGCAccgaatcATG 269 putative phage-encoded
peptidoglycan binding
protein
1-269/270 73 Burkholderia pseudomallei
K96243
YP_106791.1
34 24300 24572 holin - AGGGGGAAAtgacATG 90 protein of unknown
function DUF754
1-88/88 67 Burkholderia sp. CCGE1001 ZP_06292819.1
35 24574 24918 putative antiholin - GGAAttgtccgaATG 114 hypothetical protein
Bpse38_23639
1-113/114 83 Burkholderia thailandensis
MSMB43
ZP_02466369.1
36 24934 25140 tail protein (X) - GGTTGAActgatctgATG 68 phage tail protein X 1-68/68 88 Burkholderia pseudomallei
7894
ZP_02487665.1
37 25140 25619 capsid
completion
protein (L)
- GAATCGaccATG 159 fels-2 prophage protein 1-159/159 86 Burkholderia thailandensis
E264
ZP_05590935.1
38 25719 26408 terminase
endonuclease
subunit (M)
- GAGCTGGtggcggcATG 229 hypothetical protein
bglu_1 g01450
1-228/229 95 Burkholderia glumae BGR1 YP_002910051.1
39 26405 27418 capsid protein
(N)
- GGAGAAcccaactcATG 337 Gp2, phage major capsid
protein, P2 family protein
1-337/337 98 Burkholderia glumae BGR1 YP_002910052.1
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6Table 3 KL3 genome annotation (Continued)
40 27454 28266 capsid
scaffolding
protein (O)
- GGTTCGAcctctctctATG 270 phage capsid scaffolding
protein (GPO)
1-270/270 95 Burkholderia glumae BGR1 YP_002910053.1
41 28345 30180 terminase ATPase
subunit (P)
+ AACGAGcggcgtATG 611 phage terminase, ATPase
subunit
1-589/589 99 Burkholderia glumae BGR1 YP_002910054.1
42 30177 31226 portal vertex
protein (Q)
+ GGAGttctattcATG 349 Gp5, phage portal protein,
pbsx family protein
1-347/351 99 Burkholderia glumae BGR1 YP_002910055.1
43 31595 31732 unknown + GATGcgcgATG 45 none
44 31722 33290 unknown - GGGGAAAGcaacatATG 522 hypothetical protein
ECO103_1901
1-526/527 54 E. coli O103:H2 str. 12009 YP_003221840.1
45 33455 34699 EcoRII-C
endonuclease
- AACGGAGcttcggggATG 414 type II restriction
endonuclease, EcoRII-C
domain protein
1-401/401 77 Candidatus Hamiltonella
defensa 5AT (Acyrthosiphon
pisum)
YP_002923978.1
46 34696 35142 Vsr endonuclease - TCGCctgATG 148 DNA mismatch
endonuclease Vsr
1-148/148 77 Burkholderia graminis
C4D1M
ZP_02883050.1
47 35142 36410 EcoRII DNA
cytosine
methylase
- AGCGAGAGcaaatATG 422 DNA-cytosine
methyltransferase
1-426/426 81 Burkholderia phytofirmans
PsJN
YP_001894783.1
48 36570 37685 unknown - AAGCTGAcgctATG 372 conserved hypothetical
protein
1-371/371 95 Burkholderia ambifaria MEX-
5
ZP_02905764.1
49 37728 38816 unknown - AGTTctctaattgacATG 362 GP30 family protein 1-362/362 96 Burkholderia ambifaria MEX-
5
ZP_02905765.1
50 38822 39526 unknown - GGGAGAAGcctgaATG 234 VRR-NUC domain protein 1-234/234 99 Burkholderia ambifaria MEX-
5
ZP_02905766.1
51 39523 40032 unknown - AGGAGttcagcATG 169 PAAR repeat-containing
protein
1-169/169 97 Burkholderia ambifaria MEX-
5
ZP_02905767.1
52 40202 40408 transcriptional
regulator
+ AAGGAGAAAtagcATG 68 phage transcriptional
regulator, AlpA
1-68/72 94 Burkholderia ambifaria MEX-
5
ZP_02905768.1
Abbreviations: RBS, ribosome-binding site; aa, amino acid; % ID, percent identity. The P2 proteins that are similar to KL3 proteins based on CoreGenes analysis are shown in brackets in the putative function column.
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6genes 31-35 encode lysis proteins and genes 38-43
encode capsid proteins (Table 1, Figure 2). In KS14,
genes 10-24 and 30 encode tail proteins, genes 25-29
encode lysis proteins and genes 31-36 encode capsid
proteins (Table 2, Figure 2). In KL3, genes 15-27, 29-30
and 36 encode tail proteins, genes 31-35 encode lysis
proteins and genes 37-42 encode capsid proteins (Table
3, Figure 2). In addition, KL3 has a three-gene DNA
modification module (discussed below): gene 45,e n c o d -
ing an EcoRII-C restriction endonuclease, gene 46,
encoding a Vsr endonuclease and gene 47,e n c o d i n ga n
EcoRII methylase (Table 3, Figure 2).
Similarity to P2
KS5, KS14 and KL3 all show similarity to enterobacteria
phage P2 [GenBank:NC_001895.1]. A four-way compari-
s o no ft h eP 2 ,K S 5 ,K S 1 4a n dK L 3g e n o m e sp r e p a r e d
using PROmer/MUMmer/Circos is shown in Figure 3.
In this comparison, regions of similarity on the same
strand are shown in green, while regions of similarity on
the opposite strand are shown in red. The majority of
similar regions among these phages are on the same
strand, except for a short conserved region in KS5 and
KL3 containing DNA methylase genes (KS5 20 and KL3
28, discussed below) on the minus strand in KS5 and on
the plus strand in KL3 (Tables 1 and 3). KS5, KS14 and
KL3 all encode proteins similar to phage P2 D, U, T, E,
E+E’, FII, FI, I, J, W, V, S, R and X (involved in tail for-
mation) and L, M, N, O, P and Q (involved in capsid
formation) (Table 4). In addition, KS5 gp8 and KL3 gp9
are similar to Ogr (transcriptional activator), KS5 gp28
is similar to Old (phage immunity protein), KS14 gp17
is similar to G (tail fiber assembly protein) and KS14
gp26/gp25 and KL3 gp32/gp31 are similar to LysBC
(Rz/Rz1-like lysis proteins, discussed below) (Table 4).
The percent identity of the similar proteins ranges from
25-64% in KS5, 24-64% in KS14 and 31-62% in KL3
(Table 4).
The genes in common between P2 and the P2-like
BCC phages are almost exclusively limited to structural
genes involved in virion formation (Table 4). Other P2
genes, such as those involved in DNA replication, phage
immunity, lysogeny and lysis are dissimilar among these
phages. A similar pattern is observed (with some excep-
tions) following CoreGenes analysis of the P2-like
phages jE202 of B. thailandensis and j52237 and
jE12-2 of B. pseudomallei (data not shown) [23]. A
likely explanation for this pattern is that, while phage
structural components predominantly interact with each
other, components from other phage systems may inter-
act with host-specific proteins (such as those involved in
transcription and DNA replication) [31,32]. KS5, KS14
and KL3 appear to have retained P2 modules for the
closely interacting capsid and tail proteins, while acquir-
ing new modules for carrying out Burkholderia host-
specific processes. These genes replace P2 genes at the
right end of the P2 genome (the TO-region), P2 Z/fun
(the Z-region) and P2 orf30 (Table 4) [33]. As it is very
common for genes not found in P2 to be identified in
these three regions in other P2-like phages, it is pre-
dicted that these loci contain genes that have been
acquired via horizontal transfer [33].
Although a phage may show relatedness to a well-
characterized phage such as P2, specific guidelines must
be used to determine both the degree of relatedness of
two phages and if the novel phage can be classified as a
“P2-like virus” in a strict taxonomic sense. Lavigne et al.
proposed the use of the comparison program CoreGenes
Figure 2 Genome maps of KS5, KS14 and KL3. Genes transcribed from the plus strand are shown above and genes transcribed from the
minus strand are shown below. The scale (in kbp) is shown on the bottom. The prophage gene order is shown for KS5 and KL3. The gene
order for KS14 (which is maintained as a plasmid prophage) was chosen based on alignment with the other two sequences. Legend: orange,
recombinase; yellow, transcriptional or translational regulation; black, insertion sequence; purple, tail morphogenesis; red, DNA modification; light
blue, lysis; dark blue, capsid morphogenesis and DNA packaging; green, reverse transcription; brown, replication and partitioning; gray, unknown
function.
Lynch et al. BMC Genomics 2010, 11:599
http://www.biomedcentral.com/1471-2164/11/599
Page 14 of 26to aid in phage taxonomic analysis [34]. This program
can be used to compare the proteomes of two or more
phages [34]. If a phage shares at least 40% of its proteins
(those with a BLASTP score ≥ 75) with a reference
phage such as P2, then these two phages can be consid-
ered as part of the same genus, while if it shares 20-39%
of its proteins with a reference phage, then they can be
considered as part of the same subfamily [34]. When
KS5, KS14 and KL3 were analyzed with CoreGenes
using P2 as a reference genome, the percentage of pro-
teins in common with respect to P2 were 51.16%,
53.49% and 53.49%, respectively. These are similar to
the percentages for jE202 (55.81%), j52237 (51.16%)
and jE12-2 (48.84%) [23]. Based on these results, KS5,
KS14 and KL3 can be classified as members of the Ped-
uovirinae subfamily and “P2-like viruses” genus [23].
Figure 3 PROmer/MUMmer/Circos comparison of the KS5, KS14, KL3 and P2 prophages. Regions of similarity on the same strand are
shown in green and regions of similarity on the opposite strand are shown in red. The scale (in kbp) is shown on the outside. The sequence
start site for the KS14 prophage (which is maintained as a plasmid) was chosen based on alignment with the other three sequences. PROmer
parameters: breaklen = 60, maxgap = 30, mincluster = 20, minmatch = 6.
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Page 15 of 26Integration site characterization
In E. coli, P2 is able to integrate at over 10 different loci,
but certain sites may be used more commonly than
others [35]. None of the three P2-like BCC phages char-
acterized here were found to integrate into a locus simi-
l a rt ot h a to fP 2 .O n l yK L 3w a sf o u n dt oh a v ea
previously characterized integration site. Following PCR
amplification and sequencing from the B. cenocepacia
CEP511 chromosome (where KL3 is carried as a proph-
age), it was determined that, like many phages, KL3
integrates into a tRNA gene. Specifically, it integrates
into the middle of a threonine tRNA gene: bp 1 of the
Table 4 CoreGenes comparison of P2, KS5, KS14 and KL3
P2 protein P2 function Similar KS5 protein (% ID) Similar KS14 protein (% ID) Similar KL3 protein (% ID)
Old phage exclusion gp28 (25%)
Tin phage exclusion
Orf91 unknown
A DNA replication
Orf83 unknown
Orf82 unknown
Orf81 unknown
Orf80 unknown
B DNA replication
Orf78 unknown
Cox transcriptional repressor; excision
C repressor
Int integrase
Ogr transcriptional activator gp8 (39%) gp9 (34%)
D tail protein gp13 (50%) gp10 (38%) gp15 (41%)
U tail protein gp14 (48%) gp11 (45%) gp16 (40%)
T tape measure protein gp15 (28%, 42%) gp12 (25%) gp17 (31%, 33%)
E tail protein gp16 (59%) gp13 (55%) gp18 (55%)
E+E’ tail protein gp17 (50%) gp14 (49%) gp19 (51%)
FII tail tube protein gp18 (48%) gp15 (48%) gp20 (48%)
FI tail sheath protein gp19 (64%) gp16 (64%) gp21 (58%)
Z/Fun phage exclusion
G tail fiber assembly gp17 (24%)
H tail fiber protein
I baseplate assembly protein gp24 (37%) gp19 (36%) gp24 (39%)
J baseplate assembly protein gp25 (48%) gp20 (49%) gp25 (44%)
W baseplate assembly protein gp26 (43%) gp21 (39%) gp26 (36%)
V baseplate assembly protein gp27 (38%) gp22 (35%) gp27 (31%)
Orf30 unknown
S tail completion protein gp29 (44%) gp23 (35%) gp29 (35%)
R tail completion protein gp30 (43%) gp24 (43%) gp30 (39%)
LysC Rz1-like gp25 (36%) gp31 (48%)
LysB Rz-like gp26 (33%) gp32 (42%)
LysA antiholin
K endolysin
Y holin
X tail protein gp36 (51%) gp30 (55%) gp36 (62%)
L capsid completion protein gp38 (45%) gp31 (39%) gp37 (43%)
M terminase small/endonuclease subunit gp39 (49%) gp32 (47%) gp38 (46%)
N major capsid protein gp40 (51%) gp33 (54%) gp39 (55%)
O capsid scaffolding protein gp41 (46%) gp34 (44%) gp40 (40%)
P terminase large/ATPase subunit gp42 (59%) gp35 (60%) gp41 (57%)
Q portal protein gp43 (57%) gp36 (54%) gp42 (55%)
Abbreviations: % ID, percent identity.
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Page 16 of 26KL3 prophage corresponds to bp 32 of the tRNA based
on comparison with a 76 bp threonine tRNA gene of B.
cenocepacia HI2424 chromosome 1 (Bcen2424_R0015,
bp 491047-491122). Other phages that integrate into
threonine tRNA genes include enterobacteria phage P22,
Shigella flexneri phage SfV and Salmonella enterica ser-
ovar Typhimurium phage ST104 [36-38]. KL3 integra-
tion should not affect threonine tRNA synthesis as bp
1-45 of KL3 has an identical sequence to bp 32-76 of
the tRNA gene.
In both B. multivorans ATCC 17616 and B. cenocepa-
cia C6433, KS5 integrates into the 3’ end of an AMP
nucleosidase gene. AMP nucleosidases convert AMP
into adenine and ribose 5-phosphate [39]. This gene has
not been previously identified as a phage integration
site. KS5 bases 1-815 (including the integration site and
the integrase gene sequence) show similarity to
sequences encoding pairs of adjacent AMP nucleosidase
and integrase genes in several Burkholderia genomes.
For example, in B. pseudomallei K96243 chromosome 2,
the AMP nucleosidase (BPSS1777) and integrase
(BPSS1776) genes are adjacent to genes annotated as
encoding a putative phage capsid related protein (frag-
ment) (BPSS1775) and putative phage-related tail pro-
tein (fragment) (BPSS1774A). Similarly, in B.
pseudomallei 1106a chromosome 2, the AMP nucleosi-
dase (BURPS1106A_A2416) and integrase (BURP-
S1106A_A2415) genes are adjacent to genes annotated
as encoding a phage portal domain protein (BURP-
S1106A_A2414) and phage tail completion protein
(BURPS1106A_A2413). The identification of phage
related genes at this site in other Burkholderia genomes
suggests that the AMP nucleosidase gene may be a con-
served integration site among some Burkholderia-speci-
fic temperate phages.
KS14 is different from other P2-like phages in that it
does not encode a tyrosine integrase. Most temperate
phages use a tyrosine recombinase (or, in rare cases, a
serine recombinase) to facilitate recombination between
the phage attP site and the host attB site [40]. KS14
encodes a serine recombinase (gp6), but this protein is
unlikely to mediate prophage integration for three rea-
sons. First, gp6 is more closely related to invertases such
as Mu Gin (49% identity, E-value: 8e
-44)a n dP 1C i n
(49% identity, E-value: 7e
-43)t h a nt oi n t e g r a s e ss u c ha s
those from Streptomyces lividans phage jC31 (29%
identity, E-value: 1.2) and Mycobacterium smegmatis
phage Bxb1 (29% identity, E-value: 3e
-4) [41-44]. Second,
gp6 lacks the conserved cysteine-rich and leucine/isoleu-
cine/valine/methionine-rich regions found in other ser-
ine integrases [45]. Third, gp6 is only 225 aa in length,
which is substantially smaller than the serine integrases
that are typically between 450-600 aa in length [45]. We
did not believe KS14 to be obligately lytic because it
encodes a putative repressor protein (gp5) and because
previously collected KS14-resistant C6433 isolates were
predicted to be lysogenized based on PCR-positivity
with KS14-specific primers (Figure 4) [19].
Phages such as P1, P7 and N15 of enterobacteria, j20
of Bacillus anthracis, jBB-1 of Borrelia burgdorferi,L E 1
of Leptospira biflexa,p G I L 0 1o fBacillus thuringiensis
and pKO2 of Klebsiella oxytoca lysogenize their hosts as
plasmids [46-53]. Because KS14 gene 39 encodes a puta-
tive ParA protein (involved in partitioning in other plas-
mid prophages), we predicted that the KS14 prophage
might exist as a plasmid [54,55]. To test this hypothesis,
we used a standard protocol for the QIAprep Spin Mini-
prep plasmid isolation kit with cells of C6433 (a KS14
host), ATCC 17616 (a KS5 lysogen), CEP511 (a KL3
lysogen), K56-2 (a lysogen of KS10, a previously charac-
terized BCC-specific phage) and five putatively lysogen-
ized KS14-resistant C6433 isolates [19,56]. These
preparations were then treated with EcoRI and the
resulting fragments were separated using agarose gel
electrophoresis. For each of the four control strains, no
distinct bands were observed (Figure 5, left). In contrast,
preparations from each of the five putatively lysogenized
strains contained identical distinct bands (Figure 5,
right). Furthermore, these bands were the same size as
those predicted and observed for an EcoRI digest of
KS14 DNA (with predictions based on a circular gen-
ome sequence) (Figure 5, far right) and sequences from
selected bands matched the KS14 genome sequence.
Based on these results, we predict that KS14 is a tempe-
rate phage that, in contrast to other P2-like phages,
lysogenizes host strains as a plasmid.
It is important to note that, although one of these
phages has been shown to be active in vivo, temperate
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Figure 4 Detection of lysogeny in KS14-resistant B. cenocepacia
C6433 isolates [19]. Bacterial genomic DNA was amplified using
KS14-specific primers. Lane 1: 1 Kb Plus DNA ladder (Invitrogen),
lane 2: DNA-free control, lane 3: C6433 control, lane 4: KS14-resistant
C6433 isolate I, lane 5: KS14-resistant C6433 isolate II, lane 6: KS14-
resistant C6433 isolate III, lane 7: KS14-resistant C6433 isolate IV, lane
8: KS14-resistant C6433 isolate V. The size of the markers (in kbp) is
shown on the left.
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Page 17 of 26phages are generally considered to be suboptimal for use
in a phage therapy protocol [19,21]. In contrast to obli-
gately lytic phages, temperate phages are associated with
superinfection immunity, lysogenic conversion and specia-
lized transduction [reviewed in] [21]. In a previous study,
we have shown that temperate BCC-specific phages can
be engineered to their lytic form by inactivating the
repressor gene [21]. This strategy could potentially be
used with the three phages described here, thus making
them more appropriate candidates for clinical use.
Morphogenesis genes
As discussed above, the KS5, KS14 and KL3 structural
genes are related to those from P2 and function to con-
struct a P2-like myovirus with a contractile tail. The
only virion morphogenesis genes of P2 that these phages
lack are G (encoding the tail fiber assembly protein,
missing in KS5 and KL3) and H (encoding the tail fiber
protein) (Table 4). Because the tail fibers are involved in
host recognition, it is expected that these proteins
would be dissimilar in phages infecting E. coli and those
infecting the BCC.
A commonly identified characteristic in tailed phages
is the expression of two tail proteins from a single start
codon via a translational frameshift [57]. These proteins
(encoded in a region between the genes for the tail tape
measure and the major tail protein) share the same N-
terminus but have different C-termini due to stop
codon readthrough in the -1 frame [57]. In P2, this -1
frameshift occurs at a TTTTTTG sequence and pro-
duces the 91 aa protein E and the 142 aa protein E+E’
from the same translational start site (Figure 6) [57,58].
KS5, KS14 and KL3 all encode proteins similar to both
Ea n dE + E ’ with percent identities ranging from 49-59%
(Table 4). Despite the relatively low degree of similarity,
the P2 frameshift site appears to be conserved amongst
these phages, suggesting that they likely use a similar
frameshifting mechanism (Figure 6). In rare cases, RNA
secondary structure can be identified downstream of the
phage frameshift sequence [21,57]. When the KS5, KS14
and KL3 E+E’ sequences 60 bp downstream of the
TTTTTTG sequence were screened for secondary struc-
ture, no predicted hairpins were identified (data not
shown). This result was anticipated based upon the
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Figure 5 Isolation of the KS14 plasmid prophage. DNA was isolated using a QIAprep Spin Miniprep plasmid isolation kit (Qiagen) and
digested with EcoRI (Invitrogen). Lane 1: 1 Kb Plus DNA ladder (Invitrogen), lane 2: B. cenocepacia C6433, lane 3: B. multivorans ATCC 17616, lane
4: B. cenocepacia CEP511 lane 5: B. cenocepacia K56-2, lane 6: blank, lane 7: 1 Kb Plus DNA ladder, lane 8: KS14-resistant C6433 isolate I, lane 9:
KS14-resistant C6433 isolate II, lane 10: KS14-resistant C6433 isolate III, lane 11: KS14-resistant C6433 isolate IV, lane 12: KS14-resistant C6433
isolate V. The size of the markers (in kbp) is shown on the left. A KS14 EcoRI DNA digest and the size of the bands predicted for this digest (> 1
kbp in size) are shown on the far right.
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Page 18 of 26absence of these structures in the P2 phage E+E’ gene
[57].
Lysis genes
In P2, the lysis module consists of five genes: Y (holin),
K (endolysin), lysA (antiholin), lysB (Rz) and lysC (Rz1)
[59,60]. The P2-like BCC phages are predicted to
encode endolysins, holins and antiholins that are dissim-
ilar to those of P2 (Table 4). KS5 gp33, KS14 gp27 and
KL3 gp33 are putative endolysins as they all have the
conserved domain pfam01471 (PG_binding_1, putative
peptidoglycan binding domain; E-values: 3e
-11,3 e
-10 and
9e
-10, respectively) and show similarity to other phage
endolysins. P2 Y is a type I holin with three transmem-
brane domains [61]. Although KS5 34,K S 1 428 and
KL3 34 are dissimilar to P2 Y, it is predicted that these
three genes encode holins because they are each imme-
diately upstream of a putative endolysin gene and they
each encode proteins that a) have three transmembrane
domains based on OCTOPUS analysis and b) show
similarity to other phage holins.
Antiholins such as P2 LysA inhibit holin activity and
delay lysis of infected cells in order to optimize the
phage burst size [59,62]. Although some phages such as
l express antiholins from a second translational start
site two codons upstream of the holin start codon,
phages such as P2 and jO1205 of Streptococcus thermo-
philus encode an antiholin from a separate gene
[63,59,64]. The location of the putative antiholin genes
KS5 35,K S 1 429 and KL3 35 is similar to that in
jO1205, in which the holin and antiholin genes are
adjacent immediately upstream of the endolysin gene (as
opposed to P2, in which gene K separates Y and lysA)
[64,59]. Based on OCTOPUS analysis, KS5 gp35 has
three transmembrane domains, while KS14 gp29, KL3
gp35 and P2 LysA have four. Based on gene organiza-
tion and protein transmembrane structure, it is pre-
dicted that the P2-like BCC phages have separate
antiholin genes in their lysis modules.
P2 encodes two proteins, LysB and LysC, that are pre-
dicted to function similarly to l Rz and Rz1 [60]. Rz is
an inner membrane protein with an N-terminal
Figure 6 Conservation of the P2 E/E+E’ frameshift sequence in KS5, KS14 and KL3. For each phage, the DNA sequence is shown in the
first line, the translation in the original frame is shown in the second line, the translation in the -1 frame is shown in the third line and the
amino acid sequence of the frameshifted protein is shown in the fourth line. The conserved TTTTTTG frameshift sequence is underlined. The
frameshift is predicted to occur after the terminal G in this sequence.
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Page 19 of 26transmembrane domain and Rz1 is a proline-rich outer
membrane lipoprotein [65]. Rz/Rz1 pairs fuse the inner
and outer membranes following holin and endolysin
activity and facilitate phage release [65]. The P2 lysC
start codon is in the +1 frame within the lysB gene,
while the lysC stop codon is out of frame in the down-
stream tail gene R [66]. In contrast, the Rz1 gene in l is
entirely contained within the Rz gene [67]. KS14 and
KL3 LysBC pairs (gp26/gp25 and gp32/gp31, respec-
tively) are similar to that of P2 (Table 4). In KS14 and
KL3, the lysC genes start approximately 160 bp
upstream from the lysB stop codon and extend into the
first 8 bp of R (gene 24 in KS14 and 30 in KL3) (Figure
7). Both KS14 and KL3 LysC proteins are predicted to
have a signal peptidase II cleavage site between positions
20 (alanine) and 21 (cysteine). Signal peptidase II clea-
vage would produce a 72 aa lipoprotein with 7 prolines
(9.7% proline) for KS14 LysC and a 74 amino acid lipo-
protein with 7 prolines (9.5% proline) for KL3 LysC.
In contrast to the P2-like lysBC gene organization
found in KS14 and KL3, the KS5 genes 32/31 have a
similar organization to l Rz/Rz1.K S 5R z 1i se n c o d e di n
the +1 frame within the Rz gene (Figure 7). It is pre-
dicted to have a signal peptidase II cleavage site between
positions 18 (alanine) and 19 (cysteine), which would
produce a 46 amino acid lipoprotein with 12 prolines
(26.1%). The differences in both gene organization and
proline content between the P2-like KS14 and KL3 LysC
proteins and the l-like KS5 Rz1 protein suggest that
KS5 may have acquired genes 31 and 32 -a n dp o t e n -
tially the entire lysis module - through horizontal trans-
fer from a phage similar to l.
Sequence elements unique to KS5 and/or KL3
Insertion sequences
Insertion sequences (ISs) are short genetic elements that
can insert into nonhomologous regions of DNA [68].
These elements, comprised of a transposase gene and
inverted repeats, create flanking direct repeats following
insertion [68]. Many mutants of well-characterized
phages have been found to carry ISs, including l and
Mu [69,70]. However, it is relatively rare for wildtype
phages to carry ISs because they can interfere with gene
expression [71]. Sakaguchi et al. determined the genome
sequence of the Clostridium botulinum phage c-st and
determined that it carries 12 ISs (5 of which are incom-
plete) [71]. Of the 284 genomes sequenced at the time,
one IS was found in each of eight phages: Burkholderia
phages jE125 and Bcep22, enterobacteria phages P1
and HK022, Lactobacillus phages jAT3 and LP65, Rho-
dothermus phage RM378 and Shigella phage Sf6 [71].
A novel insertion sequence (named ISBmu23 in
vB_BmuZ-ATCC 17616) is found in the KS5 genome
between gene 12, encoding a membrane protein and
gene 13, encoding the tail protein D (Table 1). This IS
does not appear to disrupt any putative ORFs and so
may not have any significant effect on phage gene
expression. ISBmu23 is 1210 bp in length and contains
two imperfect 16 bp inverted repeats (Table 1, Figure
8). In KS5, it is flanked by two copies of a 5 bp direct
repeat, CCTAA. ISBmu23 encodes a 330 aa transposase
that has the conserved domain COG3039 (transposase
and inactivated derivatives, IS5 family; E-value: 8e
-29).
This protein is most similar to the transposase of
ISBmu2 (85% identity), an IS5-like IS present in nine
copies in ATCC 17616 [72]. ISBmu2a n dI S Bmu23 are
very similar as they a) are present in the same genome,
b) are both 1210 bp in length, c) encode similar 330 aa
transposases, d) have similar 16 bp inverted repeats (the
right inverted repeats of ISBmu2 and ISBmu23 are iden-
tical, while the left repeats differ by 3 bp) and e) prefer-
entially integrate into CTAA sequences (Figure 8).
Ohtsubo et al. found that the transposition of ISs in
ATCC 17616 increased when the cells were grown at
high temperatures [72]. Because these temperatures are
similar to what the cell may encounter during infection
of an animal or human, it is suggested that this change
may provide a selective advantage to ATCC 17616 by
modifying its genome under in vivo conditions [72].
Further experiments are required to determine if
Figure 7 Organization of the lysBC genes in KS5, KS14 and KL3. R genes (KS5 30,K S 1 424 and KL3 30) are shown in light gray, lysB genes
(KS5 32, KS14 26 and KL3 32) are shown in dark gray and lysC genes (KS5 31, KS14 25 and KL3 31) are shown in white. The scale (in bp) is
shown below.
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Page 20 of 26ISBmu23 transposition is affected by temperature and if
this IS may provide a selective advantage to KS5 lyso-
gens in vivo.
Reverse transcriptases
Reverse transcriptases (RTs) are RNA-dependent DNA
polymerases most commonly associated with retro-
viruses and retrotransposons [73]. RTs have also been
identified in several phage genomes, including those of
P2-like phages [74-76]. One function of these proteins
was extensively characterized in Bordetella bronchisep-
tica phage BPP-1. This phage has the ability to change
its host range by making amino acid substitutions in its
tail fiber protein, Mtd (major tropism determinant) [77].
This switch requires the phage-encoded RT Brt (Borde-
tella RT) that synthesizes a DNA copy of a 134 bp locus
(the template repeat, TR) that has 90% identity with a
134 bp region of the mtd gene (the variable repeat, VR)
[77,74]. Adenines in the reverse transcribed copy of TR
are mutagenized and the altered DNA integrates or
recombines at VR by an unknown mechanism, generat-
i n gat a i lf i b e rg e n ew i t hm u l t i p l eb a s es u b s t i t u t i o n s
[74,75].
A second function associated with phage RTs is phage
exclusion. In Lactococcus lactis,e x p r e s s i o no ft h ep u t a -
tive RT AbiK lowers the efficiency of plating of infecting
phages by an unknown mechanism (potentially involving
single-strand annealing recombinases) [78]. Expression
of Orf570, an RT identified in the P2-like enterobacteria
prophage P2-EC30, was found to inhibit T5 infection of
E. coli [76]. When a region of Orf570 containing an RT
conserved motif was deleted, T5 infection was no longer
inhibited [76].
KS5 encodes a putative RT, gp44. This protein has the
conserved domain cd03487 (RT_Bac_retron_II, reverse
transcriptases in bacterial retrotransposons or retrons;
E-value: 2e
-45). It is unlikely that gp44 and Brt have the
same function: the two proteins show minimal similarity
(21% identity, E-value: 7e
-4), gene 44 is located distal to
the tail fiber gene (in contrast to brt and mtd), neither
nucleotide substitutions in the tail fiber gene nor varia-
tions in KS5 tropism were observed and no repeated
sequences were identified in the KS5 genome longer
than 28 bp [77]. When compared to Orf570, gp44
shows almost no relatedness (41% over 12/546 amino
acids; E-value: 2.7) but is found at the same locus (in
the prophage, both orf570 and 44 would be located
proximal to the portal protein gene Q). Further experi-
ments are required to determine if the KS5 RT is
involved in tropism modification, phage exclusion or
some uncharacterized function.
DNA methylation, restriction and repair
DNA methylase and endonuclease genes are commonly
found in phage genomes. Methylases modify the DNA
such that it becomes resistant to bacterial restriction
systems [79]. Although P2 does not encode any putative
methylases, such proteins are encoded by both KS5 and
KL3 (KS5 gp20 and KL3 gp28 and gp47) (Tables 1 and
3). All three methylases are predicted to belong to the
AdoMet_MTase superfamily (cl12011; S-adenosyl-
methionine-dependent methyltransferases). KS5 gp20 is
most similar to a DNA methylase N-4/N-6 domain pro-
tein of B. ambifaria M E X - 5( 8 9 %i d e n t i t y ) .K L 3g p 2 8i s
most similar to a site-specific DNA methyltransferase of
B. pseudomallei K96243 (78% identity). Both of these
proteins have the conserved domain pfam01555
(N6_N4_Mtase, DNA methylase; KS5 gp20 E-value: 5e
-
22, KL3 gp28 E-value: 4e
-25). Because this domain is
associated with both N-4 cytosine and N-6 adenine
methylases, these proteins may have either cytosine or
adenine methylase activity [80]. KL3 gp47 shows similar-
ity to a modification methylase EcoRII from several bac-
terial species, with E-values as low as 4e
-114.T h i s
protein has the conserved domain cd00315
(Cyt_C5_DNA_methylase, Cytosine-C5 specific DNA
methylases; E-value: 6e
-68) and so can be classified as a
cytosine-C5 methylase. KS5 gp20 and KL3 gp28 are
likely involved in protecting the phage DNA from BCC
restriction systems. As discussed below, the function of
Figure 8 Comparison of the ISBmu23 and ISBmu2 insertion sequences.A )S t r u c t u r eo fI S Bmu23. IR, inverted repeats. Relative positions of
the inverted repeats and transposase gene (in bp) are shown below. B) Alignment of the ISBmu2 and ISBmu23 inverted repeats. Non-consensus
bases are underlined. ISBmu2 sequences are from Ohtsubo et al. [72]. L, left repeat; Ri, right repeat inverted.
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Page 21 of 26KL3 gp47 is likely to protect the phage DNA from a
phage-encoded restriction enzyme.
Phage nucleases have a number of functions, including
degradation of the bacterial DNA (to both inhibit the
host and provide nucleotides for the phage), phage
exclusion and DNA processing [81]. KL3 encodes two
endonucleases, gp45 and gp46. Gp45 is most similar to
a type II restriction endonuclease, EcoRII-C domain
protein of Candidatus Hamiltonella defensa 5AT
(Acyrthosiphon pisum) (77% identity). This protein has
the conserved domain pfam09019 (EcoRII-C, EcoRII C
terminal; E-value: 6e
-65). Gp46 is most similar to a DNA
mismatch endonuclease Vsr of Burkholderia graminis
C4D1M (77% identity). This protein has the conserved
domain cd00221 (Vsr, Very Short Patch Repair [Vsr]
endonuclease; E-value: 9e
-38).
The organization of genes 45-47 (encoding an EcoRII-
C endonuclease, Vsr endonuclease and EcoRII methy-
lase, respectively) in a single module suggests that the
proteins that they encode are functionally related. The
EcoRII-C endonuclease (which has a CCWGG recogni-
tion sequence where W = A or T) is likely to degrade
either bacterial DNA to inhibit the host during the KL3
lytic cycle or superinfecting phage DNA [81,82]. KL3
DNA would be protected from this cleavage by EcoRII
methylation at the second position in the EcoRII-C
recognition sequence (forming CC
mWGG where C
m =
5-methylcytosine) [83]. Expression of the Dcm methy-
lase, which has an identical recognition sequence and
methylation site as EcoRII methylase, is mutagenic in E.
coli because 5-methylcytosines are deaminated to thy-
mines, causing T/G mismatches [84,85]. EcoRII methy-
lase expression would presumably cause mismatched
sites in KL3 with the sequence C(T/G)WGG. In E. coli,
these mismatches are repaired by very short patch (VSP)
repair which starts with the recognition and nicking of
the sequence C(T/G)WGG by a Vsr endonuclease [86].
As KL3 expresses a Vsr endonuclease, it could repair
post-methylation T/G mismatches using the same
mechanism.
The proposed model for methylase and endonuclease
interaction during the KL3 lytic cycle is as follows.
Unmethylated host DNA (or, alternatively, superinfect-
ing phage DNA) is degraded by gp45. KL3 DNA is pro-
tected from gp45 degradation by gp47-mediated
conversion of cytosine to 5-methylcytosine. These 5-
methylcytosine bases are deaminated to thymine, but
the resulting T/G mismatches are cleaved by gp46 and
fixed using VSP repair. Although further experiments
are required to test the validity of this model, KL3
appears to encode an elegant system for degradation of
bacterial or superinfecting phage DNA, protection of the
phage genome and repair of resulting mutations.
Conclusions
This study is the first to identify and characterize P2-
like phages of the BCC. Like other previously character-
ized P2-like Burkholderia phages, KS5, KS14 and KL3
share structural genes with P2 but encode dissimilar
accessory proteins. KS5, a 37236 bp prophage of B. mul-
tivorans ATCC 17616, integrates into an AMP nucleosi-
dase gene, has a l-like Rz/Rz1 cassette, carries an
ISBmu2-like insertion sequence and encodes a reverse
transcriptase. KS14, a 32317 bp phage previously shown
to be active against B. cenocepacia in vivo,e n c o d e sa
serine recombinase but is maintained as a plasmid
prophage [19]. KL3, a 40555 bp prophage of B. cenoce-
pacia CEP511, integrates into a threonine tRNA gene
and encodes a series of proteins capable of degrading
bacterial or superinfecting phage DNA, methylating the
phage genome and repairing methylation-induced mis-
matches. As KS14 has already been shown to be active
in vivo, characterization of these three related phages is
an important preliminary step in the development of a
phage therapy protocol for the BCC.
Methods
Bacterial strains and growth conditions
BCC strains used for phage isolation and propagation
were obtained from Belgium Coordinated Collection of
Microorganisms LMG Bacteria Collection (Ghent,
Belgium) and the Canadian Burkholderia cepacia com-
plex Research and Referral Repository (Vancouver, BC).
Many of the strains used are from the Burkholderia
cepacia complex experimental strain panel and updated
experimental strain panel [29,87]. Strains were grown
aerobically overnight at 30°C on half-strength Luria-Ber-
tani (LB) solid medium or in half-strength LB broth
with shaking. Transformations were performed with
chemically-competent DH5a (Invitrogen, Carlsbad, CA),
plated on LB solid medium containing 100 μg/ml ampi-
cillin and grown aerobically overnight at 37°C. Strains
were stored in LB broth containing 20% glycerol at -80°
C.
Electron microscopy
To prepare samples for transmission electron
microscopy, phage lysates were filter sterilized using a
Millex-HA 0.45 μm syringe driven filter unit (Millipore,
Billerica, MA), incubated on a carbon-coated copper
grid 5 minutes at room temperature and stained with
2% phosphotungstic acid for 2 minutes. Micrographs
were taken with the assistance of the University of
Alberta Department of Biological Sciences Advanced
Microscopy Facility using a Philips/FEI (Morgagni)
transmission electron microscope with charge-coupled
device camera at 140,000-fold magnification.
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Isolation of KS5 from onion soil and KS14 from Dra-
caena sp. soil has been described previously [25,19].
KL3 was isolated from a single plaque on a lawn of B.
cenocepacia CEP511. The plaque was isolated using a
sterile Pasteur pipette, suspended in 1 ml of suspension
medium (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 10
mM MgSO4, 0.01% gelatin solution) with 20 μlC H C l 3
and incubated 1 hour at room temperature to generate
a KL3 stock. KL3 was propagated on B. ambifaria LMG
17828 in soft agar overlays: 100 μlo fp h a g es t o c ka n d
100 μl of liquid culture were incubated 20 minutes at
room temperature and 3 ml of soft nutrient agar was
a d d e dt ot h i sm i x t u r e ,p o u r e do n t oh a l f - s t r e n g t hL B
solid medium and incubated overnight at 30°C.
Phage genomic DNA was isolated using a modified
version of a l proteinase K/SDS lysis protocol [88].
Half-strength LB agarose plates (prepared with soft
nutrient agarose) showing confluent phage lysis were
overlaid with 3 ml of suspension media and incubated
f o r6h o u r sa t4 ° Co nap l a t f o r mr o c k e r .T h el y s a t ew a s
pelleted by centrifugation at 10 000 × g for 2 minutes
and filter-sterilized using a 0.45 μm filter. 10 ml of
lysate was treated with 10 μlD N a s eI / 1 0μlD N a s eI
buffer and 6 μl RNase I (Fermentas, Burlington, ON)
and incubated 1 hour at 37°C. Following addition of 0.5
M EDTA (pH 8.0) to 20 mM, proteinase K to 50 μg/ml
and SDS to 0.5%, the solution was mixed and incubated
1 hour at 37°C. Standard phenol:chloroform extraction
and ethanol precipitation were then used to purify the
phage DNA. Samples were resuspended in TE (pH 8.0)
and quantified using a NanoDrop ND-1000 spectrophot-
ometer (Thermo Scientific, Waltham, MA).
KS14 plasmid prophage DNA was isolated from five
putatively lysogenized KS14-resistant C6433 isolates [19]
using a QIAprep Spin Miniprep kit (Qiagen, Hilden,
Germany). Lysogeny was predicted using PCR with
KS14-specifc primers (KS14F: GCAGCTAACC-
GAGTCGCACG, KS14R:
CTCTGAAAAGGTGGGCGGTGG) (Sigma-Genosys,
Oakville, ON) and TopTaq DNA polymerase and buffers
(Qiagen). B. multivorans ATCC 17616 and B. cenocepa-
cia C6433, CEP511 and K56-2 were used as negative
controls. 2 ml aliquots of 16 hour overnight cultures
(OD600: 2.0-2.2) were pelleted, washed 3× with sterile
H2O to remove exogenous phages and treated using the
standard kit protocol. For each sample, 2 20 μlE c o R I
(Invitrogen) reactions each containing 17 μl of plasmid
DNA were digested overnight, pooled and separated on
0.8% (wt/vol) agarose gels in 1× TAE (pH 8.0).
Sequencing and bioinformatics analysis
Preliminary sequence analysis was performed using a
shotgun cloning protocol. Phage DNA was digested
using EcoRI (Invitrogen), separated on 0.8% (wt/vol)
agarose gels, purified using the GeneClean II kit (Qbio-
gene, Irvine, CA), ligated into pUC19 or pGEM-7Z and
transformed into DH5a (Invitrogen). Following blue-
white selection on LB solid medium containing 100 μg/
ml ampicillin, constructs with phage DNA inserts were
isolated using a QIAprep Spin Miniprep kit (Qiagen),
digested using EcoRI and viewed using gel electrophor-
esis. Inserts were sequenced with the assistance of the
University of Alberta Department of Biological Sciences
Molecular Biology Service Unit using an ABI 3730 DNA
analyzer (Applied Biosystems, Foster City, CA).
Sequences were edited using EditView and aligned using
AutoAssembler (Perkin-Elmer, Waltham, MA). For
completion of the three genomes, DNA samples were
submitted for pyrosequencing analysis (454 Life
Sciences, Branford, CT). Gaps between the assembled
sequences were filled following PCR amplification and
cloning using primers (Sigma-Genosys) designed to
amplify across the gaps, TopTaq DNA polymerase and
buffers (Qiagen) and the CloneJET PCR cloning kit (Fer-
mentas). The complete genome sequences of KS5, KS14
and KL3 were deposited in GenBank with the accession
numbers GU911303, HM461982 and GU911304,
respectively.
Annotation of the assembled sequences was performed
using GeneMark.hmm-P http://exon.biology.gatech.edu
[89]. For KS5, annotations were based on those of the
ATCC 17616 chromosome 2 sequence (GenBank:
NC_010805.1; BMULJ_03640 - BMULJ_03684,
bp 477496-514731). Manual annotations were performed
for the E+E’ and lysC/Rz1 genes. Proteins were numbered
based on the order of the genes in the prophage (i.e. the
integrase gene was named 1 and the integrase was named
gp1). Relatedness of the predicted proteins was assessed
using BLASTP http://blast.ncbi.nlm.nih.gov[90]. Protein
transmembrane domains, stem-loop structures and signal
peptide cleavage sites were identified using OCTOPUS
http://octopus.cbr.su.se, mfold http://mfold.rna.albany.
edu and LipoP http://www.cbs.dtu.dk/services/LipoP,
respectively [91-93]. Repeat sequences in the DNA were
identified using REPuter http://bibiserv.techfak.uni-biele-
feld.de/reputer[94]. Restriction sites were predicted using
NEBcutter http://tools.neb.com/NEBcutter2[95]. Whole
genome sequence comparisons were performed using
CoreGenes with a stringency setting of 75 http://www.
binf.gmu.edu/genometools.html[96,34]. Comparison fig-
ures were constructed using PROmer/MUMmer http://
mummer.sourceforge.net Circos http://mkweb.bcgsc.ca/
circos[97,98].
To identify the KS5 prophage insertion site in ATCC
17616, the assembled KS5 sequence was compared to
the vB_BmuZ-ATCC 17616 sequence in a BLASTN
search and the left prophage junction was determined.
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Page 23 of 26Primers designed to this region (KS5attLF:
TGCACGGCGAGCTGAAACTG, KS5attLR: GAAGG-
CACGCGAGGTAGAACG) were used to amplify the
C6433/KS5 prophage junction in C6433 lysogens. To
identify the KL3 insertion site in CEP511, the region
proximal to the KL3 integrase gene 1 was analyzed
using BLASTN and found to be similar to a region con-
taining a tRNA-Thr gene in several Burkholderia strains
including B. ambifaria AMMD (Bamb_R0016; chromo-
some 1, bp 403358-403433). Primers designed to this
region (KL3attLF: AGCTGCAGATGGGTAAC-
GAGTGG, KL3attLR: CCACTCACGAAGGG-
CAAGCTG) were used to amplify the CEP511/KL3
prophage junction.
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